Magnesium sits at the crossroads of two trends brands abroad ask about: Japan’s tidy, fixed nutrient-function wording, and the wider “magnesium for sleep” interest driven by consumer social media. The two are not the same claim, and mixing them up is the easiest way to overstate a Japan-made magnesium product.
This guide separates what Japan’s system permits from what independent sleep research actually shows, and explains why the magnesium salt form matters more for this ingredient than for most other minerals — both for absorption and for a very ordinary side effect that Japan’s own regulator requires you to warn about.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a magnesium product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A systematic review of randomised controlled trials found the evidence for oral magnesium and sleep inconsistent and low-certainty overall, though one recent, well-designed trial of a specific magnesium form found a modest benefit for self-reported sleep symptoms.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Systematic review of randomised controlled trials (2026, PubMed 42661485) | Twelve RCTs of oral magnesium supplementation on sleep, insomnia or poor sleep, across varied populations, magnesium forms, doses and outcome measures | Findings were inconsistent across subjective and objective sleep measures; the authors concluded current evidence does not support oral magnesium as a routine treatment for insomnia, though it may offer modest benefit for some subjective outcomes in some adults, with low or very low overall certainty |
| Randomised, double-blind, placebo-controlled trial, Nature and Science of Sleep 2025 (PMID 40918053, PMCID PMC12412596) | 155 healthy adults aged 18–65 reporting poor sleep, given 250 mg elemental magnesium as magnesium bisglycinate (with 1,523 mg glycine) or placebo daily for 4 weeks | Insomnia Severity Index scores fell more with magnesium bisglycinate (−3.9) than placebo (−2.3), a statistically significant but small difference (p = 0.049, Cohen’s d = 0.2) |
The honest reading of these two results together: the field-wide picture is mixed and low-certainty, while a single recent trial of one specific, well-absorbed magnesium form found a real but modest effect. Neither supports a strong “magnesium cures insomnia” claim.
Checked against the published abstracts on 12 October 2026.
What Japanese products say
Japan’s Foods with Nutrient Function Claims (栄養機能食品) system lets a magnesium product use fixed sentences about bones and teeth, energy production and blood circulation once the daily amount falls inside a set range, without any premarket approval.
Under the Consumer Affairs Agency’s Food Labeling Standards (Appended Table 11 / 食品表示基準 別表第11), as revised with effect from 1 October 2026, magnesium qualifies as a Food with Nutrient Function Claims when the daily intake amount stated on the label contains between 96 mg and 320 mg of magnesium. The upper limit was 300 mg before the revision, and processed foods made or imported up to 31 March 2030 may still follow the previous rules.
The three permitted function statements (our translation) are:
- “Magnesium is one of the nutrients needed to build bones and teeth.”
- “Magnesium is one of the nutrients that help produce energy.”
- “Magnesium is one of the nutrients that help keep blood circulation normal.”
None of these statements mentions sleep, stress or relaxation — so a Japan-labelled magnesium product cannot use this wording to reference the sleep research above.
The mandatory caution statement (our translation) reads: “This product does not cure disease or further improve health through excessive intake. Taking a large amount of magnesium may cause loose stools (diarrhoea). Follow the daily recommended amount. Infants and young children should avoid this product.” The loose-stool warning is not a formality — it reflects a genuine, dose-dependent laxative effect that differs by magnesium salt, discussed below.
💬 Need an evidence summary for your regulatory adviser that separates Japan’s notified wording from the sleep-research literature? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe magnesium by its notified function or by the specific, modest sleep-research result — never as a general or strong sleep remedy.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains magnesium, one of the nutrients that help produce energy” with the amount per serving | ”Cures insomnia” or “guarantees better sleep" |
| "Studied in a 2025 randomised trial using magnesium bisglycinate at 250 mg, with a modest result” | Implying the sleep result applies to any magnesium form or dose |
| ”May cause loose stools at higher intakes” as an honest note | Omitting the laxative effect that Japan’s own caution wording requires |
How magnesium is formulated
Magnesium salts differ substantially in absorption and in gastrointestinal tolerability, so the salt choice is the single biggest formulation decision for this mineral.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or capsule | Standard, precise dosing | Larger doses may need a larger or divided tablet given magnesium’s bulky salts |
| Powder or drink stick | Evening-routine or “relax” products | Taste varies significantly by salt; some salts are also used deliberately for a laxative effect at higher doses |
Decisions that shape the specification:
- Salt form and absorption. Published data indicates magnesium aspartate, citrate, lactate and chloride are absorbed more completely (roughly 28–33% fractional absorption in the cited data) than magnesium oxide or magnesium sulfate (around 4% for oxide) — a roughly seven-fold difference. Magnesium bisglycinate (magnesium bound to the amino acid glycine) is described in the literature as well absorbed and gentle on the stomach, and is the form used in the 2025 sleep trial above.
- Amount per serving. For a Japanese Foods with Nutrient Function Claims product, the daily amount from the label must sit between 96 mg and 320 mg under the rules in force from 1 October 2026. Japan’s own 2025 dietary reference intakes set the tolerable upper intake level for magnesium from sources other than ordinary food (i.e. from supplements) at 350 mg/day for adults — no separate upper limit applies to magnesium from food.
- Companion ingredients. Magnesium is frequently combined with other “relax” or “sleep” ingredients. Every companion ingredient, especially herbal ones, needs its own check against Japanese food law.
- Managing the laxative effect. Because higher-absorption forms still carry a dose-dependent loose-stool risk, and lower-absorption forms like magnesium oxide are sometimes chosen deliberately for their laxative effect in other product categories, be explicit with your factory about which effect you want and at what dose.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Magnesium salts commonly used in foods are well established in Japan. As with the other minerals in this series, the risk in a “relax” or “sleep support” formula usually sits in companion botanicals, some of which Japan treats as medicines. See the Japan-made supplement OEM page, and our GABA guide for a second example of reading limited, low-certainty evidence honestly.
Before you ask for a quotation
A factory can quote accurately once the magnesium salt, the amount, the form and the companion ingredients are fixed.
- Magnesium salt form (citrate, oxide, bisglycinate or other) and amount per serving
- Whether you intend to use Japan’s Foods with Nutrient Function Claims wording, and if so, confirmation the amount falls inside 96–320 mg
- Dosage form — tablet, capsule, powder or drink stick
- Companion ingredients and their amounts
- Whether a laxative effect is wanted or should be minimised
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made magnesium product? Send us the concept — salt form, amount, format and the countries you will sell in.
Frequently asked questions
1. Does magnesium actually help you sleep?
The overall trial evidence is inconsistent and rated low-certainty by a 2026 systematic review, which concluded oral magnesium is not supported as a routine insomnia treatment. A single 2025 randomised trial of magnesium bisglycinate at 250 mg found a modest, statistically significant improvement — evidence for that specific form and dose, not for magnesium generally.
2. What can a Japan-made magnesium product say on its Japanese label?
If the daily amount is between 96 mg and 320 mg, it can carry wording about building bones and teeth, producing energy and keeping blood circulation normal, plus a mandatory caution about loose stools and about infants and young children. It cannot reference sleep through this route.
3. Which magnesium salt absorbs best?
Published absorption data ranks aspartate, citrate, lactate and chloride well above oxide and sulfate. Bisglycinate is separately described as well absorbed and gentle on the stomach, and is the form used in the recent sleep trial.
4. Why does magnesium cause loose stools?
Unabsorbed magnesium draws water into the bowel, a dose-dependent, well-known effect that Japan’s regulator requires every magnesium Foods with Nutrient Function Claims label to mention. It affects lower-absorption salts like oxide more noticeably at a given dose.
5. What is the upper intake limit for magnesium?
Japan’s 2025 dietary reference intakes set 350 mg/day as the tolerable upper intake level for magnesium taken from sources other than ordinary food, such as supplements — with no separate limit for magnesium from food itself.
Sources: “Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials”, 2026 (PMID 42661485); “Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial”, Nature and Science of Sleep 2025 (PMID 40918053, PMCID PMC12412596); Consumer Affairs Agency, Food Labeling Standards Appended Table 11 as revised by Cabinet Office Order No. 89 of 2026 (in force 1 October 2026), for the Foods with Nutrient Function Claims range, function wording, caution wording and transitional period for magnesium; Consumer Affairs Agency, material 2 to the Consumer Commission food labelling subcommittee (6 August 2026), for Japan’s 2025 tolerable upper intake level of supplemental magnesium (350 mg/day); NIH Office of Dietary Supplements Magnesium Health Professional Fact Sheet, via search summary, for comparative absorption data across magnesium salt forms. Checked on 12 October 2026.